| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3943553 | Gynecologic Oncology | 2013 | 6 Pages |
Abstract
⺠HOXB5 and HOXB8 are differentially expressed at various anatomic sites in serous ovarian carcinoma. ⺠HOXB5 expression is higher in post-chemotherapy disease recurrence effusions compared to pre-chemotherapy primary diagnosis effusions. ⺠Higher HOXB8 expression in effusions is associated with shorter overall and progression-free survival in serous ovarian carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Helene Tuft Stavnes, Arild Holth, Trinh Don, Janne Kærn, Olga Vaksman, Reuven Reich, Claes G. Trope', Ben Davidson,